Mainz Biomed N.V. (Nasdaq: MYNZ)

https://www.mainzbiomed.com

LinkedIn: https://www.linkedin.com/company/mainz-biomed

Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. ColoAlert is currently marketed across Europe with FDA clinical study and submission process intended to be launched in the first half of 2022 for U.S. regulatory approval. Mainz Biomed’s product candidate portfolio includes PancAlert, an early-stage pancreatic cancer screening test based on Real-Time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples, and the GenoStick technology, a platform being developed to detect pathogens on a molecular genetic basis. *

	Start	2021-11-11 existent
	Industry	molecular diagnostics
	Industry 2	ColoAlert colorectal cancer test
	Person	Baechler, Guido (Mainz Biomed 202111 CEO before Singulex 201305– CEO before SVP Operations before Roche Dx)
	Person 2	Eidens, Moritz (Mainz Biomed 202111 CSO before PharmGenomics GmbH 201601 Managing Director)

	Region	Mainz
	Country	Germany
	Street	50 Robert-Koch-Str. Sirius Gutenberg Park
	City	55129 Mainz
	Tel	+49-6131-55428-60
		Address record changed: 2021-11-16

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Mainz Biomed N.V.. (11/8/21). "Press Release: Mainz Biomed Commences Trading on Nasdaq Under Ticker Symbol ‘MYNZ’". Berkeley, CA & Mainz.

		Record changed: 2022-04-28

Picture [iito] No Content Marketing 650x100px

More documents for Mainz Biomed N.V. (Nasdaq: MYNZ)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)